FIELD: nanotechnology.
SUBSTANCE: invention relates to the use of nanoparticles for prevention and/or treatment of cancerous diseases, when the nanoparticles are injected with anti-cancer therapeutic agent, and the nanoparticles and anti-cancer agent are simultaneously present in the patient's body. The nanoparticles are free from binding with the anti-cancer medicinal product and have a coating which contains polycondensated aminosilanes.
EFFECT: simultaneous presence of nanoparticles and the anti-cancer therapeutic agent in the body of patients enables to increase the activity of the said anti-cancer agent with simultaneous reduction of the side effects.
12 cl, 1 tbl, 13 dwg, 196 ex
| Title |
Year |
Author |
Number |
| MAGNETIC NANOPARTICLE FOR TREATING AND/OR PREVENTING CANCER, BASED INFUSION SOLUTION AND PHARMACEUTICAL COMPOSITION |
2006 |
- Valdehfner Norbert
- Dehken Klaus
- Jordan Andreas
- Shol'Ts Regina
|
RU2490027C9 |
| IMPLANTED PRODUCTS, CONTAINING NANOPARTICLES |
2009 |
- Tizen, Burgkhard
- Jordan Andreas
|
RU2524644C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING CANCER AND ITS METASTASES |
2006 |
|
RU2401662C2 |
| COMBINED IMMUNOTHERAPEUTIC APPROACH TO CANCER TREATMENT |
2015 |
|
RU2716821C2 |
| PHARMACEUTICAL COMBINATION FOR TREATMENT AND/OR CHEMOSENSITISATION OF TUMOURS RESISTANT TO ANTICANCER DRUGS |
2007 |
- Perea Rodriges Sil'Vio Ehrnesto
- Perera Negrin Jasser
- Rodriges Ulloa Ar'Elis
- Khil Valdes Kheovanis
- Ramos Gomes Jassel'
- Kastel'Janos Serra Lila Rosa
- Betankur Nun'Es Lasaro Iram
- Sanches Puehnte An'El'
- Fernandes De Kossio Dorta Duke Khorkhe
- Asevedo Kastro Boris Ehrnesto
- Gonsales Lopes Luis Khav'Er
- Besada Peres Vladimir
- Alonso Daniel' Fernando
- Gomes Daniel' Ehduardo
|
RU2396974C2 |
| COMBINED THERAPY WITH (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PIRAZOLE-4-YL)-1-OXO-2,6-DIHYDRO-1H-[1,2]DIAZEPINO[4,5,6-cd]INDOLE-8-YL)ACETAMIDE |
2007 |
- Ehnderes Kenna Linn
- Blazina Alessandra
|
RU2409361C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING N-CHLOROPHENYLCARBAMATE OR N- CHLOROPHENYLTHIOCARBAMATE, COMPOSITION OF STANDARD MEDICINAL FORMULA AND METHOD OF TREATMENT OF CANCER PATIENTS |
1996 |
|
RU2170577C2 |
| 17ALPHA-BENZOATE OF CORTEXOLONE FOR USE IN TREATING TUMOURS |
2015 |
|
RU2712752C2 |
| SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT |
2001 |
|
RU2264217C2 |
| 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN TREATMENT OF TUMOURS |
2015 |
|
RU2712950C2 |
